BOSTON--(BUSINESS WIRE)--May 9, 2006--Point Therapeutics, Inc. (NASDAQ: POTP - News) today reported financial results for the fiscal quarter ended March 31, 2006. Point reported a net loss of $7,857,000 or $0.24 per basic and diluted share in the first quarter of 2006, compared with a net loss of $4,915,000, or $0.25 per basic and diluted share, in the first quarter of 2005.
